RxDoctor Payments Data

Behrad Aynehchi, MD

Otolaryngology/Facial Plastic Surgery · Culver City, CANPI 1275709040

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $985, 3.2 times the $304 reported in 2019.

$3,050in general payments, 2019–2025

Across 115 payments — averaging $26.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$695
  • Stryker$694
  • GSK$462
  • AbbVie$233
  • Acclarent, Inc$178
  • Sanofi$173
  • plus $614 from 13 others

What the payments were for

  • Food & beverage$3,050100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,050 in reported general payments places this provider in the 70th percentile of 102 otolaryngology/facial plastic surgery providers in California.

See all otolaryngology/facial plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$396,829
Medicare patients
458
Services billed
1,124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate137$1,449
Azelastine Hcl41$751
Mupirocin90$580
Ofloxacin12$355
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav48$355
Fluocinolone Acetonide Oil12$315
Doxycycline Hyclate48$295
Ipratropium Bromide12$275
Cefdinir11$245
Azithromycin26$106
Methylprednisolone14$87
Tramadol Hcl37$79
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$51
Prednisone22$25
Lorazepam28$24

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Culver City

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →